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The E Box Motif CAGGTG
Enhances Somatic Hypermutation
without Enhancing Transcription
to act on a variety of target genes that are normally
excluded from SHM (Martin et al., 2002; Yoshikawa et
al., 2002). How this potentially dangerous process is
normally limited to certain target genes is one of the
major questions in the study of B cell gene expression.
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levels of AID combined with a specific targeting mecha-University of Chicago
Chicago, Illinois 60637 nism which limits the process to Ig genes and a subset
of other genes in normal SHM. The targeting appears to
be related to transcription initiation. When the promoter
associated with the variable region of Ig genes is dupli-Summary
cated upstream of the constant region, that region which
is normally spared from SHM becomes mutated (PetersThe frequency of somatic hypermutations of an Ig 
transgene with an artificial test insert, RS, is at least and Storb,1996). We have postulated that a mutator
factor, which now presumably is AID, becomes associ-4-fold higher than that of three related transgenes.
The four transgenes differ only in the sequence of a ated with the transcription complex near the promoter,
travels with that complex during transcript elongation,96 bp insert within the variable region. RS is hypermu-
table over the total 625 nucleotides of the variable/ and is deposited on the DNA, perhaps when the poly-
merase pauses (Storb et al., 1999).joining region. The RS insert contains two CAGGTG
sequences, potential binding sites for basic helix- The specific association of AID with the mutable target
genes is likely to be regulated by cis elements near theloop-helix proteins. Changing CAGGTG to AAGGTG
reduces the mutability to that of the non-RS trans- target genes which upon interaction with specific trans-
acting factors direct AID to the target genes. In a previ-genes without altering the mutation pattern. The
CAGGTG motif enhances somatic hypermutation with- ous study of the importance of certain sequences in the
mutability of Ig  transgenes, we found one transgene,out enhancing transcription. A DNA probe containing
the two CAGGTG sites, but not AAGGTG, binds E47 RS, that was mutated severalfold more highly than other,
very similar, transgenes (Michael et al., 2002). The onlyand gives rise to two specific EMSA bands with nuclear
extracts from mutating cells. Possible actions of this difference between these  transgenes was the se-
quence of a 96 bp test insert within the variable region.enhancer of somatic hypermutation are discussed.
The current study is an analysis of the cis elements
present in the RS test insert that are the cause of thisIntroduction
enhancement of somatic hypermutation.
The process of somatic hypermutation (SHM) of Ig genes
is initiated when mature B lymphocytes encounter an Results
antigen that is recognized by its B cell receptor. SHM
takes place in germinal centers of lymphoid tissues. The RS Transgene Is Highly Mutable
SHM alters the primary sequence of the Ig variable re- The RS transgene is from a panel of Ig  transgenes
gions of the expressed heavy and light chain genes that differ from each other by the insertion of a 96 base
(Storb et al., 1999). The mutations occur within a stretch pair mutation substrate designed to test the contribution
of 1 to 2 kb from the Ig gene promoter but do not extend of potential secondary structure of the substrate DNA or
into the constant region. B cells that have acquired mu- its transcribed RNA in targeting somatic hypermutation
tations that increase the affinity of their B cell receptor (Figure 1A, XS) (Michael et al., 2002). The insert unique
for the immunizing antigen are selected for survival and to the RS transgene was modeled on the EPS sequence,
may become long-lived memory B cells. used in this lab as a diagnostic mutation substrate, that
It appears likely that the molecular events of SHM consists of alternating EcoRV and PvuII restriction en-
are triggered by the action of the activation-induced zyme sites (Figures 1A and 1B) (Klotz et al., 1998; Mi-
deaminase (AID) which causes the deamination of cyto- chael et al., 2002). The RS transgene has six repetitions
sines in the target genes (Bransteitter et al., 2003; of GGTGCT, a sequence that can anneal with its inverted
Chaudhuri et al., 2003; Dickerson et al., 2003; Ramiro repeat within the transcribed mRNA (Figure 1C). The
et al., 2003; reviewed in Diaz and Storb, 2002; Storb and analysis of this panel of transgenes, while concluding
Stavnezer, 2002). Normally, SHM is restricted to Ig genes that potential secondary structure of the RNA transcript
and also affects human BCL6, mouse Mb-1, B29, and is unlikely to target mutation, demonstrated that the RS
presumably a few other genes (Gordon et al., 2003; Pas- transgene was mutated at a greater frequency than the
qualucci et al., 1998; Peng et al., 1999; Shen et al., 1998). other test transgenes, the non-RS (EPS-EPS, NS, NHS),
Several non-Ig genes that are expressed in mutating B both by the number of mutated clones recovered and
lymphocytes are not targeted by the SHM process (Shen the number of mutations per clone (Michael et al., 2002).
et al., 2000). However, if AID is overexpressed, it appears On the basis of this and subsequent studies with a total
sample of nine RS mice (from two different RS trans-
genic lines) and four mice from three non-RS lines,*Correspondence: stor@midway.uchicago.edu
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Figure 1. The Transgenes and Their Fre-
quencies of Somatic Hypermutation
(A) Diagram of the transgenes. The triangles
represent the inserted EPS control and XS
test sequences. L, leader; V, variable; J, join-
ing; C, constant gene segments; MAR, matrix
attachment region; and InE and 3E,  gene
enhancers.
(B) The mutable 5 end of the transgenes. The
numbers indicate the number of nucleotides
from the start of transcription. Domains of
transgenes analyzed for mutations are F1,
control EPS, M, XS (the test sequence; the
only 96 nt that differ between the different
transgenes), and F2.
(C) The sequence of the 96 bp RS insert (at
XS in [B]). The two CAGGTG sequences are
underlined. The two C→A changes in RSA
are boxed. The lowercase nt at either end are
from the M and F2 domains flanking RS. The
vertical bar indicates the boundary of the 43
and 61 bp probes used in the EMSA assays
(Figure 5).
(D) The number of mutations per 104 nucleo-
tides in PNAhi B cells from the RS, RSA, and
non-RS transgenic mice. A total of 1389 and
193 DNA clones from the two-copy and the
nine-copy RS mice, and 981 and 557 clones
from the two different two-copy RSA mice,
respectively, were analyzed. The domains are
indicated in (B).
15.2% of the 1582 RS DNA clones from PNAhi B cells The Increased Mutability of the RS Transgene
Is Due to Two CAGGTG E Box Motifswere mutated compared to 7.4% of the 2006 non-RS
clones. The proportion of DNA clones that was mutated The sequence of the RS insert was examined and com-
pared to gene domains that are required for Ig expres-varied among mice, ranging from 10% to 28% of RS
clones and 6% to 9% of non-RS clones. The mutations sion and somatic hypermutation, in particular, the Ig
heavy and light chain gene enhancers. Common motifsidentified in this study were limited to the 625 nucleo-
tides in positions 468 to 1092 from the start of transcrip- were also sought in the postulated regulatory domains
of the human BCL6 gene known to be a target of somatiction. The frequency of mutation of this entire region was
at least 4-fold higher in the RS mice, with the average hypermutation (Pasqualucci et al., 1998; Peng et al.,
1999; Shen et al., 1998). The E box CAGGTG occurs infrequency of 14.3  104 for the RS and 3.5  104
for the non-RS. The mutation frequency of the different all. This sequence, CAGGTG, occurs twice in the RS
insert, separated by 13 nucleotides (Figure 1C).transgenes is shown in Figure 1D. The data are displayed
in arbitrary sequence domains (F1, EPS, M, and F2) that To test whether the CAGGTG sequence played a role
in the high mutability of the RS transgene, a new trans-are common in all transgenes; the only domain that is
different among the transgenes is XS. The number of gene, RSA, was made in which these sequences were
changed to AAGGTG, a sequence that does not associ-mutations of the RS transgene is consistently higher in
all domains compared with the RSA and non-RS trans- ate with E box binding proteins (Hsu et al., 1994; Massari
et al., 2000), and two independent transgenic mousegenes. In addition, the number of mutations per clone
reached as high as 58 in the RS, compared to a maxi- lines were studied. Mutations were analyzed in PNAhi B
cells of five RSA mice. Among the 1538 RSA DNA clonesmum of 18 in the non-RS mice (Figure 2). It is clear that
the insert unique to the RS transgene has increased the sequenced, the percent of mutated clones recovered
was 9.4%, and the mutation frequency was 2.0  104.mutability of the locus.
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Figure 2. Mutations per Mutated DNA Clone
The numbers of mutations (1 to 58) are shown for the 625 nucleotides sequenced in the indicated mutated DNA clones. The total number of
mutated clones was 240 for RS, 144 for RSA, and 148 for the non-RS mice.
Both values are considerably lower than in the RS mice. 1998d; Winter and Gearhart 1998). Removal of either 
In addition, the maximum number of mutations per clone enhancer greatly diminished SHM (Betz et al., 1994).
was only six, with most clones having only a single The placement of a Vpromoter adjacent to the constant
mutation (Figure 2). The patterns of mutation and the region in an Ig transgene resulted in the mutation of the
targeting of SHM “hot spots” was, however, the same constant region, which is normally spared, coincident
in RS and RSA transgenic mice (Figure 3). Thus, the with transcription initiating from that promoter (Peters
change of only 2 nucleotides, the first C in each E box and Storb, 1996). In other studies, increased mutation
of the RS insert, abolished the high mutability character- was correlated with increased transcription (Bachl et al.,
istic of the RS transgene and resulted in a frequency of 2001; Fukita et al., 1998). Our working model of somatic
mutation of the RSA transgene that is similar to the non- hypermutation directly links mutation and transcription
RS transgenes (Figures 1D and 2). by proposing that the transcribing polymerase delivers
an essential mutator factor to the mutation substrate
(Storb et al., 2001). E boxes are binding sites for proteinsThe Increased Mutability of RS Is Not Due
that function mainly as activators of transcription (Mas-to Increased Transcription
sari et al., 2000). The placement of two E boxes in theThe process of somatic hypermutation is linked to tran-
scription of the target locus (reviewed in Storb et al., mutable region of the RS transgene, about 900 nucleo-
Figure 3. Location of Mutations
The number of all mutations in a given position of the 625 nucleotides sequenced for the RS transgenes are shown on the top and for RSA
on the bottom of the graph. The EPS and RS/RSA regions are indicated.
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The DNA protein complexes were resolved by gel elec-
trophoresis (Figure 5).
With Ramos cell nuclear extracts, two protein com-
plexes (1 and 2) are formed on the 61 bp DNA fragment
from the 3 end of the RS insert that contains both E
boxes (Figure 5). These complexes are not formed on
the same fragment from the RSA insert (Figure 5) or on
the 43 bp fragment that is at the 5 end of the RS insert
(data not shown). Both complexes 1 and 2 are depen-
dent on intact CAGGTG since competition with cold 61-
mer RS, but not RSA, eliminates or greatly reduces both
bands. When the RS probe is incubated with a truncated
E47 protein that contains the E box binding peptide, a
specific band, complex 3, is formed (Figure 5, IVT). This
band is greatly diminished if the E47 protein is first incu-Figure 4. mRNA Levels in RS and RSA Transgenic Mice
bated with an antibody to E47 that apparently precludesThe data are from real-time RT-PCR analyses comparing the trans-
binding to DNA. Incubating Ramos or BL2 (another mu-genic and endogenous C mRNA levels with those of -actin in two
tating cell line) nuclear extracts with this antibody toRS and two RSA mice from different litters. The endogenous mRNA
levels are calculated as total C mRNA minus transgene mRNA. hi, E47 also precludes formation of complex 1 (Figure 6A),
lo, RS, or RSA RNA from PNAhi or PNAlo B cells. Ck, endogenous  while antibodies to E12 (Figures 5 and 6A), FenI, Topo II,
mRNA from PNAhi B cells. pol II, AID, and other E box proteins, such as HEB and
c-myc (data not shown), have no consistent effect on
complex formation or migration in the gel. A different anti
tides from the promoter, may have affected the tran- E47 antibody supershifts complex 1 (Figure 6A, lane 3).
scription of the gene. E47 is known to be the predominant form of E2A in
To determine whether the increased mutability of the B cells (Shen and Kadesh, 1995). The binding of Ramos
RS transgene was correlated with increased transcrip- cell nuclear proteins to the 61 bp fragment is inhibited
tion of the locus, RNA was harvested from splenic B by either of two 21 bp oligonucleotide probes containing
cells of immunized RS and RSA mice. With semiquantita- either E box and its adjacent bases (data not shown),
tive PCR there appeared to be more transgene mRNA indicating that either E box alone can bind the same
in PNAhi/B220 B cells of RSA than of RS mice (data proteins. Also, probes from the 3 end of the RS insert,
not shown). Indeed, with real-time PCR, the relative containing the C to A change in either the first or the
amounts of RSA transcripts in both PNAhi and PNAlo B second E box, give rise to complexes of equal intensity
cells were approximately 4-fold higher than RS tran- and mobility (data not shown), indicating that either site
scripts (Figure 4). This difference in steady-state RNAs can bind the nuclear proteins. Complex 1 is not formed
and the implied difference in transcription rates is in- with nuclear extracts from HeLa or uninduced CL-01
versely correlated with the mutability of the RS and RSA cells, a B cell line that can be induced to undergo SHM
transgenes. The difference between the RS and RSA (Zan et al., 1999) (Figure 6B). Our HeLa and CL-01 lines
lines was not due to differences in the overall immune do not produce detectable levels of E47 protein (by
status of the mice. They have similar levels of endoge- Western blot; data not shown).
nous C transcripts (Figure 4) and respond with similar The proteins in the second specific complex, complex
titers of hemagglutinins (RS, 1:64 and 1:512; RSA, 1:128 2, are unknown. The intensity of the complex is com-
and 1:512) to immunization with sheep red blood cells. peted by cold-specific probes containing the intact RS
Thus, the role of the CAGGTG E boxes in increasing the E box, but not RSA. However, the complex is barely, if
mutability of the RS transgene is apparently not due to at all, affected by antibodies to E47 or E12 (Figures 5
and 6B), or any of the other antibodies used (see above;increased transcription of the mutation substrate.
data not shown). It is likely that complex 2 does not
contain E47. This complex is present with nuclear ex-
tract of CL-01 cells (Figure 6B) which, as noted above,Proteins that Bind CAGGTG-Containing DNA Probes
do not contain E47.The RS E box sequence CAGGTG is the preferred core
sequence for binding the E2A protein E47 (Hsu et al.,
1994). The change to AAGGTG is predicted to no longer Discussion
bind this protein or other bHLH proteins (Hsu et al.,
1994; Massari et al., 2000). To test this prediction and The RS  transgene is at least four times more highly
to look for other protein complexes that might form on mutable than similar  transgenes. The only difference
the DNA of the RS insert, we made probes with the 3 between the RS and the EPS-EPS, NS, and NHS trans-
61 nucleotides of the RS and RSA inserts (Figure 1C) or genes is the 96 nucleotide pairs placed at position 866
with 44 RS nucleotides in which both E boxes were from the V promoter which differ at many sites (XS in
CAGGTG, or either the first or the second E box con- Figure 1B) (Michael et al., 2002). The RS insert causes
tained the C to A change. Radiolabeled probes were a higher mutability not only in this insert but over the
incubated with proteins in nuclear extracts from Ramos total 625 nucleotides analyzed (Figure 1D), suggesting
cells or in vitro transcribed and translated truncated that it may contain a general enhancer of SHM. The
mutation enhancement is due to this insert and not the(IVT) E47. Ramos is a constitutively mutating B cell line.
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Figure 5. Electrophoretic Mobility Shift
Assays
IVT E47, in vitro-translated, truncated E47
protein; Ramos NE, Ramos cell nuclear ex-
tract; DNA, 32P-labeled RS or RSA probe, re-
spectively; aE47 and aE12, anti-E47 and anti-
E12 antibodies; NE, nuclear extract; cold RS
and cold RSA, unlabeled probes; 100, 200,
excess of unlabeled probes to labeled probe.
The probes are described in the Experimental
Procedures (see also Figure 1C).
chromosomal environment, since two independent RS The CAGGTG sites were accidentally created in the
RS insert when two of the six repeats of GGTGCT weretransgenic lines showed this effect, while none of the
mice with the other three transgenes (EPS-EPS, NS, placed adjacent to CA which is present at the same
position in all four transgenes. CAGGTG is an E boxNHS; Michael et al., 2002) showed such enhancement.
which is expected to bind basic helix-loop-helix proteins
(Massari et al., 2000). The abolishment of the high SHM
levels by mutating these motifs to AAGGTG in RSA trans-
genic mice shows that the CAGGTG motifs are responsi-
ble for the SHM enhancement (Figure 1). Again, the re-
duction in SHM was seen in two independent RSA
transgenic lines and is therefore not due to the chromo-
somal insertion site. Furthermore, the two RS mouse
lines and two RSA mouse lines had similar levels of
endogenous C transcripts and responded with similar
hemagglutinin titers to immunization with sheep red
blood cells, so their different levels of SHM of the trans-
genes was not due to differences in general immunologi-
cal status. We have also determined that upon immuni-
zation the RS mice respond with normal, not elevated,
levels of SHM in endogenous S107 VH genes (Kim, 2000).
DNA probes of the 3 end of the RS insert containing
the two CAGGTG sites bind E47 protein, a product of
the E2A gene (Figure 5). E47 is a major E box binding
basic helix-loop-helix protein in mature B cells (Massari
et al., 2000; Shen and Kadesh, 1995). E12, a different
splice product of the E2A mRNA (with a different DNA
binding region) is present in smaller amounts in these
cells (Shen and Kadesh, 1995). Proteins in nuclear ex-
tracts of the SHM-competent Ramos cells form specific
complexes with the 3 end of the RS insert, but not RSA
which has AAGGTG in place of CAGGTG. Also, there is
no specific binding of nuclear proteins to the 43 nt of
the 5 end of the RS insert. The Ramos cell extract
results in two major shifted bands with the RS probe
after gel electrophoresis (Figure 5). Band 1 must contain
E47, since it is essentially eliminated by certain anti-E47
antibodies (Figure 5) and the complex is supershifted
Figure 6. Electrophoretic Mobility Shift Assays to a slower migrating species with other anti-E47 anti-
(A) Lane 1, probe alone; lanes 2–4, probe with Ramos nuclear bodies (Figure 6A). Band 1 may be a homodimer of E47.
extract the indicated antibodies. The minor complex in the middle Homodimers of E47 exist only in B cells, apparently
of the gel is not shifted with any of the antibodies used. It varies in because E47 becomes phosphorylated in other cell
different experiments and may contain degraded proteins present types, preventing homodimerization (Sloan et al., 1996).
in the major complexes.
However, band 1 may also be a heterodimer of E47 with(B) The first lane of the three sets is probe with nuclear extract of
a known or unknown protein.the indicated cell lines. The other lanes contain, in addition, the
indicated antibodies. While the proteins in band 1 may be involved, we do
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not know whether any of the proteins present in the sion involves E2A sites (e.g., mb-1, B29, 5, and CD19).
complexes seen in the gel shift assays play a role in the The former two are mutable by SHM in normal B cells
enhancement of SHM by the RS insert. E47 is a potential (Gordon et al., 2003). -5 is only expressed in pre-B
candidate. CAGGTG is its optimal binding site (Hsu et cells, and CD19 has not been tested for SHM. It appears
al., 1994). This sequence is present in all Ig enhancers. unlikely that CAGGTG, while present in Ig enhancers,
In most it is present in one copy in this orientation. In would by itself specifically direct SHM to Ig genes. We
the 3  enhancer it is present in two copies in inverted assume that the Ig (and BCL6, etc.) gene specificity of
orientation (CACCTG) and in the heavy chain intron en- SHM is based on preferential association of AID (the
hancer in one copy each in either orientation. Any Ig postulated mutator factor [Storb and Stavnezer, 2002])
enhancer appears sufficient for SHM (reviewed in Storb with Ig (BCL6, etc.) genes. When AID is overexpressed
et al., 1998d). E47, and to some extent E12, is essential in nonmutating B cell hybridomas or fibroblasts, SHM
for the early development of B lymphocytes (Bain et al., (and CSR) is induced (Martin et al., 2002; Yoshikawa et
1997). E47 and E12 are likely involved in the opening al., 2002). It appears that there is a fine balance between
of chromatin around the Ig genes (Choi et al., 1996; AID expression and targeting. At physiological levels of
Romanov et al., 2000). Whether E47 and/or E12 are also AID, the enzyme is preferentially associated with Ig (and
essential for Ig transcription enhancer function in mature BCL6, etc.) genes. At higher levels, AID may associate
B cells is not known (Y. Zhuang, personal communica- with any transcribed gene. The cis element CAGGTG,
tion). However, expression in mature B cells of Id3, an or rather, as yet undefined proteins bound to it, may
antagonist of E2A activity, does not inhibit the produc- enhance the binding to or activity of AID within the re-
tion of IgM (Quong et al., 1999) (while it inhibits switch spective gene (see below). Whether CAGGTG is actually
recombination), suggesting that, indeed, E2A is not re- required, in combination with other as yet unidentified
quired for Ig gene transcription. In any case, the pres- cis elements, for Ig-specific targeting of SHM is un-
ence of two copies of the E47 binding site CAGGTG in known.
the RS transgene does not enhance transcription of the The distribution of mutations is the same in RS and
transgene (Figure 4). Thus, the CAGGTG sites in the RSA mice (Figure 3) and is the same as in the non-RS
RS transgene are apparently true enhancers of somatic mice (Michael et al., 2002). The mutation pattern is a
hypermutation. The identity of the nuclear proteins that reflection of the presence of hot spots and cold spots
bind these sites and enhance SHM remains to be deter- of SHM (Shapiro et al., 1999; Michael et al., 2002). The
mined. two C to A changes in RSA do not overlap with any
It is not known why RSA transgene mRNAs are at a RGYW/WRCY SHM hot spots. It appears likely that the
higher level than RS mRNAs. This is unlikely due to SHM hot spots represented by the motif RGYW/WRCY
different stabilities of the two -mRNAs since their se- are hot spots because they are the preferred targets for
quences are identical, except for the two C to A changes. AID. They are still major targets in uracil DNA glycosy-
The difference in transcription does not seem to be due lase (UDG)-deficient mice (Diaz and Storb, 2002; Rada
to SHM effects, since it is also seen with transgene RNA et al., 2002; Storb and Stavnezer, 2002). In these mice,
from PNAlo B cells. It is not due to a more active immune the predicted events after the deamination of cytosine
status of the RSA mice, since both lines of mice have to uracil are vastly different from those in UDG wild-
similar levels of endogenous  gene transcripts and pro- type mice (Diaz and Storb, 2002; Rada et al., 2002). If
duce similar levels of antibodies upon immunization. The the hot spot targeting were due to a post-uracil event,
difference in transgene transcripts may be interesting, the targeting should be greatly different in UDG-defi-
possibly indicating that the presence of extraneous cient mice. Given these considerations, it is an interest-
CAGGTG sites interferes with activity of the bona fide ing possibility that the SHM enhancement by CAGGTG
promoter or enhancers. It is possible that extra copies may be due to enhanced recruitment or activation of
of CAGGTG inhibit transcription, as E2A sites have been
AID at the RS transgene. The challenge is now to deter-
found to bind negative regulators (Azmi et al., 2003). It
mine how Ig gene specificity and enhancement of so-
has been reported that the levels of SHM follow the
matic hypermutation are related.levels of Ig transcripts in mutating B cells (Bachl et al.,
2001; Fukita et al., 1998). This is not the case for the
RS and RSA transgenes. It is possible that a certain Experimental Procedures
threshold level of transcription is required for SHM and
Transgenic Micethat in both the RS and RSA mice this threshold is satis-
The RS and non-RS mice were described in Michael et al. (2002).fied. Alternatively, the SHM-enhancing effect may over-
The non-RS mice carry either one of three different transgenes,compensate for the low transcription level in the RS
EPS-EPS, NS, and NHS (Michael et al., 2002). RSA was made by
transgene, or CAGGTG within the gene may slow down oliogonucleotide-directed site-specific PCR mutagenesis of the RS
the elongation rate of transcription, thus enhancing the insert in its Bluescript pSKAshuttle vector. The HpaI RSA fragment
chance for AID deposition. was then cloned into the BsrBI site of the Vk167/PEPS plasmid,
What is the mechanism of enhancement of SHM by modified to retain only the transgene BrsBI site. Transgene DNA
was prepared as the 12.5 kb AatII/Asp718 fragment, gel purified,CAGGTG cis elements? This hexamer is theoretically
and used to make transgenic mice at the NICHD Transgenic Mousepresent about once every 4000 bp in the mouse genome.
Development Facility operated by the University of Alabama at Bir-The human BCL6 gene which has CAGGTG sites in the
mingham. Low copy number founder animals were identified and
postulated regulatory region in its first intron (Dalla- characterized as described (Klotz et al., 1998; Michael et al., 2002).
Favera et al., 1996) is mutable by SHM (Pasqualucci et The founders and subsequent generations of transgenic animals
al., 1998; Peng et al., 1999; Shen et al., 1998). There are were bred to C57BL/6 mice and maintained on food that was not
irradiated. Two independent RS and two independent RSA trans-other non-Ig genes expressed in B cells whose expres-
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genic lines were analyzed. Their transgene copy numbers were RS, Additional probes containing both CAGGTG sites in the context of
the RS fragment or one or the other site mutated to AAGGTG were2 and 9; RSA, 2 and 2.
synthesized as 44-mer oligonucleotide pairs. The unmutated 44-
mer sequence is CCATGGACAGGTGCTACACTGCAGACCAGGTGImmunization of Transgenic Mice
CTACCAGAATTC; when mutated, the sequence has an A in placeMice were injected i.p. with 2  108 washed sheep red blood cells
of one or the other C. All oligonucleotides were synthesized by the(SRBC) on days 1 and 8. The mice were sacrificed, and blood and
University of Chicago Oligonucleotide Synthesis Facility. Probesspleen were removed 6 days after the last injection. Serum anti-
were 5 end labeled with 32P-	_ATP in a reaction with T4 polynucleo-SRBC agglutinating antibody titers were determined by serial dilu-
tide kinase (NEB).tion assays.
Nuclear extracts were made from cultured Ramos cells by a modi-
fied method of Dignam (Michael and Roizman 1989) and stored asClones of Transgenic Sequences from B Cells
aliquots at80
C. Proteins were synthesized cell free using plasmidB cells were prepared from Peyer’s patches or immunized mice
pB4X encoding truncated E47 (a gift of Y. Zhuang) and the reagentsspleens from transgenic mice aged 4–7 months. Cells were stained
and protocol provided in the kit Rabbit Reticulocyte Lysate (Pro-with PE-anti-mouse CD45/B220 (Pharmingen), FITC-GL7 (Phar-
mega). Protein concentration was determined using the Bio-Radmingen), and FITC-PNA (Sigma), and sorted by FACStarPLUS or MoFlo
Protein Assay Kit.(Becton Dickinson). The B220,PNAhigh and B220,PNAlow popula-
Mobility shift assays were performed as described (Eisenbeis ettions of cells were collected. DNA was made, and transgene se-
al., 1993). In general for each reaction, approximately 20,000 cpmquences were amplified by PCR and cloned as described (Michael
radiolabeled probe and 0.5 g dIdC competitor are mixed with pro-et al., 2002)
teins in nuclear extracts (5 g/reaction) in binding buffer (20 mM
Tris [pH 7.6]/50 mM KCl/ 0.05% NP40/5% glycerol/1 mM EDTA) forIdentification of Somatic Mutations
15 min at room temperature; the set of reactions are run on a 5%Mutations in a transgene were detected by SSCP followed by DNA
acrylamide gel, in 0.5 TBE at 150 V for approximately 2 hr. Whensequencing (Klotz et al., 1998; Michael et al., 2002) or by direct
antibody is added prior to complex formation, a dilution of the anti-sequencing (University of Chicago Cancer Research Center DNA
body (usually 1:300 dilution) is incubated with the nuclear extract forSequencing Facility).
15 min prior to addition of DNA and competitor, and the incubation is
continued for 15 min. Alternatively, after complex formation, anti-Data Searches
body is added to the reaction mix at 15 min, and the incubation isPotential known motifs with nuclear functions were sought using
continued for 15 min. Cold competitor DNA is added to the radiola-the website www.cbil.upenn.edu/cgi-bin/tess.
beled probe and dIdC mix prior to addition of protein.
RNA Quantitation by Real-Time PCR
Protein Gels and Western BlotsRNA was made from splenic B cells harvested from immunized mice
These were carried out as per standard protocols.and sorted into PNAhi,B220 and PNAlo,B220populations as before.
Cells were lysed and RNA prepared using RNAqueous (Ambion)
Antibodiesreagents and protocol, recovered in 100 l, and stored at 80
C.
Antibodies to the following proteins were used for probing WesterncDNA was made using 8 l RNA as template with SuperScript First
blots or in mobility shift assays. E47: 1600022 Geneka (supershiftsStrand Synthesis System for RT-PCR (Invitrogen). Real-time PCRs
complex 1); sc763 Santa Cruz (blocks formation of complex 1);were run and analyzed on the Smart Cycler (Cepheid), using a proto-
554077 BD Pharmingen (blocks formation of complex 1). E12: sccol of 95
C, 900 s; 95
C, 15 s; 60
C, 60 s (optics on); 45 cycles, and
762 Santa Cruz. FenI: sc 8794 Santa Cruz; HEB sc 357 SantaCruz;a manual threshold of 30 fluorescent units. Reactions were prepared
c-myc 13-2500 Zymed.in triplicate with SYBR Green JumpStart Taq ReadyMix (Sigma) and
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